Home › NDC Lookup › RxCUI directory › RxCUI 2282414

Bempedoic acid 180 MG Oral Tablet [Nexletol] — RxCUI 2282414

RxNorm drug concept · Semantic branded drug
RxCUI 2282414 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2282414
Official nameBempedoic acid 180 MG Oral Tablet [Nexletol]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNexletol 180 MG Oral Tablet
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)11,416 prescriptions · 31 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bempedoic Acid: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Nexletol does two things depending on why your doctor prescribed it. If you're at higher risk for heart disease and can't tolerate statins, it helps lower the chance of a serious e...
  • What exactly is Nexletol supposed to do for me?
  • Nexletol was specifically developed for people who can't tolerate recommended statin doses, so that situation is exactly what it's designed for. It works differently from statins a...
  • Can I take Nexletol if statins made my muscles hurt?
📖 Read our full Bempedoic Acid guide →

🕸️ Concept Web — How Bempedoic acid 180 MG Oral Tablet [Nexletol] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Bempedoic acid 180 MG Oral Tablet [Nexletol] RxCUI 2282414

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Bempedoic acid 2282403
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Nexletol 2282409
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bempedoic acid Oral Tablet 2282407
    • Bempedoic acid Oral Product 2282405
    • Bempedoic acid Pill 2282406
    • Bempedoic acid Oral Tablet [Nexletol] 2282411
    • Nexletol Oral Product 2282412
    • Nexletol Pill 2282413
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bempedoic acid 180 MG Oral Tablet SCD · 2282408
  • Bempedoic acid 180 MG SCDC · 2282404
  • Bempedoic acid Oral Tablet SCDF · 2282407
  • Bempedoic acid Oral Product SCDG · 2282405
  • Bempedoic acid Pill SCDG · 2282406

Brand-Name Concepts

  • Bempedoic acid 180 MG [Nexletol] SBDC · 2282410
  • Bempedoic acid Oral Tablet [Nexletol] SBDF · 2282411
  • Nexletol Oral Product SBDG · 2282412
  • Nexletol Pill SBDG · 2282413
  • Nexletol BN · 2282409

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2282414 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72426-0118-03 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72426-118-03) Nexletol Esperion Therapeutics, Inc. 2020-03-06
72426-0118-99 7 TABLET, FILM COATED in 1 BLISTER PACK (72426-118-99) Nexletol Esperion Therapeutics, Inc. 2020-03-06
Observed labelers: Esperion Therapeutics, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$13.8155
Range $13.8155–$13.8155 · middle 50% $13.8155–$13.8155 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.